Krebs Biochemicals & Industries (KREBSBIO) Share Price Fall Streak: Second Straight Session of Decline
- October 6, 2026
- Posted by: Kunal Singla
- Category: News
Krebs Biochemicals & Industries Share Price Fall Streak has now extended to its second straight session, with the stock last trading at Rs 58 after a cumulative 16.43% decline from the streak start base price of Rs 69.40. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established. This keeps the focus on the move itself rather than on a fresh trigger, and on how the fall has unfolded across two successive sessions.
For readers tracking Krebs Biochemicals & Industries Share Price Fall Streak, the relevant context is that the company remains a Micro Cap with a market capitalisation of Rs 137.88 crore. A two-session run of lower closes is different from a one-off fall because it shows persistence in the price move, and it makes valuation, sector positioning and peer comparison more important in today’s read of Krebs Biochemicals & Industries Share Price Fall Streak.
Krebs Biochemicals & Industries (KREBSBIO) Share Price Fall Streak: Consecutive Decline Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 58 |
| Previous Close | Rs 63.95 |
| Today's Move | -Rs 5.95 (-9.3%) |
| Open | Rs 62.76 |
| High | Rs 64.13 |
| Low | Rs 57.16 |
| Market Capitalisation | Rs 137.88 crore |
Krebs Biochemicals & Industries Share Price Fall Streak was visible again today as the stock moved from a previous close of Rs 63.95 to Rs 58, a decline of Rs 5.95 or 9.3%. The day open was Rs 62.76, while the stock touched a high of Rs 64.13 and a low of Rs 57.16. That means Krebs Biochemicals & Industries Share Price Fall Streak traded well below the day’s opening level and finished near the lower end of the range, but still above the session low. The market capitalisation stood at Rs 137.88 crore, keeping the company in the Micro Cap category. For Krebs Biochemicals & Industries Share Price Fall Streak, the important point is that the second straight lower close is now backed by a visible two-day pattern, not just one isolated move. The next step is to see whether the fundamental picture offers any offset to the price event.
What the Consecutive Declines Show
Krebs Biochemicals & Industries Share Price Fall Streak now covers two sessions, and the cumulative change of -16.43% from the streak start base price of Rs 69.40 is more important than the single-day decline alone. A second straight session of lower closes shows that the latest move is part of a run, not a one-session event. For Krebs Biochemicals & Industries Share Price Fall Streak, the first lower close sets the base and today’s decline extends it further, which is why the streak lens matters more than a single-day snapshot. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the next question less about cause and more about whether the valuation, profitability and sector benchmark are consistent with the current share price.
Krebs Biochemicals & Industries (KREBSBIO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 137.88 crore |
| P/B Ratio | -0.83x |
| ROCE | -15.38% |
| EPS | Rs -6.54 |
| Book Value Per Share | Rs -76.64 |
| Dividend Yield | 0% |
Krebs Biochemicals & Industries (KREBSBIO) fundamental metrics show P/B -0.83x, ROCE -15.38%. These figures provide context only and are not a buy or sell signal.
Krebs Biochemicals & Industries has a market capitalisation of Rs 137.88 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at -0.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROCE of -15.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -6.54, book value per share of Rs -76.64, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 31.79x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.58x to 668.09x |
| Company P/B Ratio | -0.83x |
| Benchmark Median P/B | 2.9x |
| Benchmark Average P/B | 4.41x |
| Benchmark Median ROE | 11.73% |
| Benchmark Average ROE | 10.65% |
| Company ROCE | -15.38% |
| Benchmark Median ROCE | 13.63% |
| Benchmark Average ROCE | 13.41% |
| Company Market Capitalisation | Rs 137.88 crore |
| Benchmark Median Market Cap | Rs 812.84 crore |
| Benchmark Average Market Cap | Rs 14,118.75 crore |
Krebs Biochemicals & Industries (KREBSBIO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Krebs Biochemicals & Industries (KREBSBIO) has a ROCE of -15.38%, which is below the benchmark median of 13.63%, a difference of -212.84%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,34,279.63 | 35.35 | 4.94 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,737.12 | 83.61 | 13.85 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,129.27 | 82.93 | 20.15 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,14,239.13 | 25.16 | 4.21 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,08,808.05 | 31.97 | 3.07 | 11.83 | 16 |
ROCE stood at -15.38% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Krebs Biochemicals & Industries (KREBSBIO) has a market capitalisation of Rs 137.88 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Krebs Biochemicals & Industries Share Price Fall Streak
- Krebs Biochemicals & Industries Share Price Fall Streak is now a second straight session, so the pattern itself is drawing attention.
- The stock last traded at Rs 58 after a 9.3% decline, and the cumulative move across the streak is -16.43%.
- The company remains a Micro Cap with a market capitalisation of Rs 137.88 crore, which keeps the share price move easy to track in context.
- Negative EPS, negative book value and negative ROCE keep the fundamental read tightly linked to the share price fall.
- The healthcare peer set provides a wide valuation and return gap, which makes Krebs Biochemicals & Industries Share Price Fall Streak stand out within the industry.
About Krebs Biochemicals & Industries
Krebs Biochemicals & Industries operates in Healthcare and the Pharmaceuticals & Drugs industry. For Krebs Biochemicals & Industries Share Price Fall Streak, the useful business context is that the company belongs to a sector where investor attention often centres on earnings strength, capital efficiency and valuation discipline. The latest Univest figures show a company with negative EPS, negative book value and negative ROCE, which is why the current share price is being read through a streak lens rather than a simple one-day move. The business context matters because it helps explain how the stock is positioned within its industry even when the latest price action is the headline event.
Track Krebs Biochemicals & Industries Share Price on Univest
Use Krebs Biochemicals & Industries (KREBSBIO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can follow Krebs Biochemicals & Industries Share Price Fall Streak on Univest for live share price tracking, key fundamental ratios, 52-week levels and market insights. Univest also helps readers compare the current share price with the company’s valuation and sector context in one place. For a stock moving through a second straight session, that kind of consolidated view is useful because it keeps the price event, fundamentals and benchmark comparison together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Krebs Biochemicals & Industries Share Price Fall Streak in focus today?
Ans. It is in focus because the stock has now posted a second straight lower close. The latest trade was at Rs 58, down 9.3% from the previous close of Rs 63.95, and the cumulative streak move is -16.43%.
What is the latest price in Krebs Biochemicals & Industries Share Price Fall Streak?
Ans. The latest trade is Rs 58. That compares with a previous close of Rs 63.95 and reflects a decline of Rs 5.95 in the latest session, keeping Krebs Biochemicals & Industries Share Price Fall Streak firmly under review.
How much has Krebs Biochemicals & Industries Share Price Fall Streak fallen across the run?
Ans. The cumulative fall across the two-session run is -16.43% from the streak start base price of Rs 69.40. That makes Krebs Biochemicals & Industries Share Price Fall Streak a clear consecutive-decline pattern rather than an isolated move.
What does the price action show in Krebs Biochemicals & Industries Share Price Fall Streak?
Ans. The stock opened at Rs 62.76, touched a high of Rs 64.13 and a low of Rs 57.16 before last trading at Rs 58. That places Krebs Biochemicals & Industries Share Price Fall Streak near the lower part of.
What is the market capitalisation in Krebs Biochemicals & Industries Share Price Fall Streak?
Ans. The market capitalisation is Rs 137.88 crore, which places the company in the Micro Cap category. In Krebs Biochemicals & Industries Share Price Fall Streak, that size context helps readers compare the move with sector and peer benchmarks.
How do the fundamentals look in Krebs Biochemicals & Industries Share Price Fall Streak?
Ans. The key fundamentals are negative EPS of Rs -6.54, negative book value of Rs -76.64, negative P/B of -0.83 and ROCE of -15.38%. In Krebs Biochemicals & Industries Share Price Fall Streak, those figures remain the central context.
How does Krebs Biochemicals & Industries Share Price Fall Streak compare with healthcare peers?
Ans. Peers such as Sun Pharmaceutical Industries, Divi’s Laboratories and Torrent Pharmaceuticals show positive return metrics and much larger market caps. Krebs Biochemicals & Industries Share Price Fall Streak therefore sits at a very different scale.
Should investors track Krebs Biochemicals & Industries Share Price Fall Streak on Univest?
Ans. Yes, because Univest lets readers track the live share price, valuation ratios, 52-week levels and market insights in one place. That helps keep Krebs Biochemicals & Industries Share Price Fall Streak alongside its sector context.
